Premium Nahrungsergänzungsmittel | artgerecht

Cluster of Differentiation (CD) – Immunology

Cluster of Differentiation (CD) is a standardized system for classifying cell surface molecules used in immunology to identify and characterize immune cells.

Regular tips about health Regular tips about health

Things worth knowing about "Cluster of Differentiation"

Cluster of Differentiation (CD) is a standardized system for classifying cell surface molecules used in immunology to identify and characterize immune cells.

What is Cluster of Differentiation?

Cluster of Differentiation (abbreviated CD) refers to an internationally standardized nomenclature system for classifying cell surface molecules, particularly those found on leukocytes (white blood cells). These molecules, also known as CD markers or CD antigens, enable the precise identification and distinction of different immune cell types. The system was first introduced in 1982 at the first International Leukocyte Typing Workshop and has been continuously expanded ever since.

Background and Significance

The human immune system consists of a wide variety of cell types that can be difficult to distinguish from one another at first glance. CD markers are specific proteins located on the surface of cells that act as molecular identification tags. By using antibodies that selectively bind to these markers, scientists and clinicians can accurately identify, count, and characterize individual cell populations.

Today, more than 400 different CD molecules have been identified and numbered. They are not found exclusively on immune cells but also appear on epithelial cells, endothelial cells, platelets, and other cell types throughout the body.

Functions of CD Molecules

CD molecules serve a wide range of biological functions, including:

Cell recognition and communication: CD markers facilitate interactions between different immune cells and the recognition of pathogens.
Signal transduction: Many CD molecules are involved in intracellular signaling pathways, regulating cell activation, proliferation, or programmed cell death (apoptosis).
Cell-cell adhesion: Certain CD markers mediate the attachment of cells to one another or to tissue matrices.
Receptor function: CD molecules serve as receptors for cytokines, growth factors, and other signaling molecules.

Key CD Markers and Their Clinical Importance

Some of the most clinically relevant CD markers include:

CD3: Specific to T lymphocytes; essential for T-cell activation.
CD4: Found on T helper cells; serves as the primary receptor through which HIV binds to cells.
CD8: Found on cytotoxic T cells, which destroy infected or malignant cells.
CD19 / CD20: Markers on B lymphocytes; therapeutic targets in lymphoma treatment (e.g., rituximab targeting CD20).
CD34: Marker on hematopoietic stem cells; clinically relevant in stem cell transplantation.
CD56: Marker on natural killer (NK) cells.
CD14: Marker on monocytes and macrophages.

Applications in Diagnostics and Therapy

Flow Cytometry

The most important diagnostic method for analyzing CD markers is flow cytometry. In this technique, cells are stained with fluorescently labeled antibodies directed against specific CD molecules and then measured using a laser-based instrument. This allows cell populations to be analyzed rapidly, precisely, and in large numbers.

Clinical Applications

CD markers are used across numerous medical fields:

Hematology and Oncology: Classification of leukemias and lymphomas based on their CD expression pattern (immunophenotyping).
HIV infection: Measurement of CD4 cell counts to assess immune status and disease progression.
Transplantation medicine: Selection and purification of stem cells based on CD34 expression.
Autoimmune diseases: Analysis of immune cell populations for diagnosis and treatment monitoring.
Immunotherapy: Targeted antibody therapies directed against specific CD molecules on tumor cells (e.g., anti-CD20, anti-CD19, anti-CD38).

CD Markers as Therapeutic Targets

The discovery of CD molecules has revolutionized modern cancer therapy. Monoclonal antibodies that specifically bind to CD markers on tumor cells can either directly destroy these cells or activate the immune system to fight them. Notable examples include:

Rituximab (anti-CD20) for B-cell lymphomas and chronic lymphocytic leukemia (CLL)
Daratumumab (anti-CD38) for multiple myeloma
Blinatumomab (a bispecific antibody targeting CD3 and CD19) for acute lymphoblastic leukemia (ALL)

CAR T-cell therapies also rely on CD molecules as target structures: T cells are genetically engineered to recognize specific CD markers on cancer cells and destroy them.

References

Zola H. et al. - CD molecules 2006: human cell differentiation molecules. In: Journal of Immunological Methods, 319(1-2):1-5, 2007. PubMed.
Abbas A.K., Lichtman A.H., Pillai S. - Cellular and Molecular Immunology, 10th Edition. Elsevier, 2022.
World Health Organization (WHO) - Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.